Charles River Laboratories India Private Limited

Charles River Laboratories India Private Limited - healthcare in Bangalore, Karnataka, India. FY 2026 financials & compliance.
CIN U24119KA2008PTC047975 Incorporated 08 October 2008 ROC Bangalore HQ Bangalore, Karnataka, India
Active Private Limited Company healthcare
Revenue · FY 2025
₹99.82 Cr
▲ 15% YoY
Net profit · FY 2025
₹5.35 Cr
Net margin 5.4%
EBITDA · FY 2025
₹7.95 Cr
EBITDA margin 8%
Authorised capital
₹30.05 Cr
Registered with MCA
Paid-up capital
₹28.79 Cr
Issued & subscribed
Company age
18 yrs
Est. 2008
Employees · EPFO
85
Provident fund records
Directors on board
5
As per MCA filings

About Charles River Laboratories India Private Limited

Data last updated:

Charles River Laboratories India Private Limited is a private limited company based in Bangalore, Karnataka, India, a subsidiary of Charles River Laboratories Holdings, France. It operates in the medical equipment retail and distribution segment of the healthcare sector. It was incorporated on 08 October 2008 and has been in existence for over 18 years.

The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24119KA2008PTC047975. Its GSTIN is 29AADCC4876C1ZL (Karnataka). The company holds 5 GST registrations, of which 4 are active.

The company has an authorised share capital of ₹30.05 Cr and a paid-up capital of ₹28.79 Cr. It is led by directors including Prafulla Krishnaji Chitnis (Managing Director) and Rajesh Puthiya Sudhakaran (Managing Director).

Its last annual general meeting (AGM) was held on 23 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No. 15 1st Floor Rest House Crescent Road, Bangalore, Karnataka, India – 560001.

As per the financials filed for FY 2025, the company reported a revenue of ₹99.82 Cr, a growth of 15% compared to the previous year. For the same year it recorded a net profit of ₹5.35 Cr (net margin 5.4%) and EBITDA of ₹7.95 Cr (EBITDA margin 8%). Revenue has grown at a compounded annual rate (CAGR) of 12% over three years and 10% over five years.

The company has about 85 employees on its provident fund (EPFO) records.

The company is associated with 2 brands: Charles River Laboratories and Cerebricon. Court records list 1 case involving the company, including 1 filed by the company. The company has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹28.78 Cr; the latest was in December 2008. Its 5 peer companies in the Healthcare industry (Healthcare Equipment Retail and Distribution), with the same principal business activity (wholesale trading) are compared by revenue, 2 larger and 3 smaller; the largest is G.S.Pharmaceutical Distributors Private Limited with revenue of ₹103.17 Cr.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website criver.com.

Company details

CIN U24119KA2008PTC047975
Registration Number 047975
Incorporation Date 08 October 2008
ROC Bangalore
Listing Status Unlisted
Company Status Active
Parent Company Charles River Laboratories Holdings, France
Compliance Status Active Compliant

Contact details

Charles River Laboratories India Private Limited's registered office is in Bangalore, Karnataka. Its website is criver.com. Its e-mail address is in the company report.

  • Email
  • Website
  • Social Media
  • Registered Address
    No. 15 1st Floor Rest House Crescent Road, Bangalore, Karnataka, India – 560001
  • Industry
    Healthcare, Medical Equipment Retail & Distribution

To see the full contact details of Charles River Laboratories India Private Limited, buy the company report.

Comprehensive company report
Charles River Laboratories India Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Charles River Laboratories India operates two associated brands: Charles River Laboratories and Cerebricon. Each brand links to its own profile.

BrandDescriptionWebsite
Provider of drug discovery and preclinical development servicescriver.com
Preclinical research services for CNS and PNS diseases are provided.cerebricon.com

Business activity

The main business activity of Charles River Laboratories India is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Charles River Laboratories India Private Limited, buy the company report.

Financials of Charles River Laboratories India Private Limited

FY 2025 filings available

Charles River Laboratories India Private Limited reported revenue of ₹99.82 Cr (up 15% YoY) for FY 2025.

Revenue · FY 2025
₹99.82 Cr ▲ 15%
Net profit · FY 2025
₹5.35 Cr margin 5.4%
EBITDA · FY 2025
₹7.95 Cr margin 8%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 15%
3 years · compounded
▲ 12%
5 years · compounded
▲ 10%
EBITDA CAGR growth
1 year
▲ 167%
3 years · compounded
▲ 26%

Revenue has grown at a compounded annual rate (CAGR) of 10% over five years, including 15% growth in the latest year. EBITDA rose 167% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹7.95 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹5.35 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin8%
Net Profit Margin5.4%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Charles River Laboratories India Private Limited, buy the company report.

Board of directors of Charles River Laboratories India Private Limited

Charles River Laboratories India has 5 current directors and 18 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Prafulla Krishnaji ChitnisManaging Director02 Jan 200917 Years 10 MonthsCurrent
Kevin John FinnDirector25 Aug 20224 Years 2 MonthsCurrent
Jon GalliDirector13 Dec 20223 Years 11 MonthsCurrent
Amro ElabbasAdditional Director11 Jun 20251 Years 5 MonthsCurrent
Rajesh Puthiya SudhakaranManaging Director12 Jan 20260 Years 10 MonthsCurrent

Peer comparison

Charles River Laboratories India Private Limited is compared with the 5 companies closest to it by revenue in the Healthcare industry (Healthcare Equipment Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
G.S.Pharmaceutical Distributors Private Limited₹103.17 Cr (FY 2025)2.0%Mumbai, Maharashtra, India
Esaote Asia Pacific Diagnostic Private Limited₹103.01 Cr (FY 2024)49.0%New Delhi, Delhi, India
Charles River Laboratories India Private Limitedthis company₹99.82 Cr (FY 2025)₹5.35 Cr5.4%15.0%85Bangalore, Karnataka, India
Vishal Surgical Equipment Company Private Limited₹98.88 Cr (FY 2025)144.0%Chennai, Tamil Nadu, India
Decent Medical Equipment Systems Private Limited₹98.24 Cr (FY 2025)21.0%Indore, Madhya Pradesh, India
Jignesh Agency Private Limited₹98.17 Cr (FY 2025)1.0%Mumbai, Maharashtra, India

To see the full peer comparison of Charles River Laboratories India Private Limited, buy the company report.

Auditor

Charles River Laboratories India Private Limited is audited by Price Waterhouse & Co. for the financial year 2021.

Auditor firmFinancial yearFirm registration number
Price Waterhouse & Co.FY 2021304026E/E300009

Shareholding

The shareholding of Charles River Laboratories India Private Limited is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2021FY 2020FY 2019FY 2017FY 2016
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Charles River Laboratories India Private Limited, buy the company report.

Deals & funding

Charles River Laboratories India Private Limited has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹28.78 Cr; the latest was in December 2008.

Total deals
2
Funding round
1
Secondary share transfer
1
Disclosed funding
₹28.78 Cr

Deals on record (2 of 2)

WhenDealAmountParties
Dec 2008Funding round₹28.78 CrInvestors: Charles river Laboratories Holding, an individual
Nov 2008Secondary share transferUndisclosedBuyer: Charles river Laboratories Holding, an individual
Seller: 2 individuals

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Charles River Laboratories India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Charles River Laboratories India Private Limited has a workforce of 85 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.

Employee count
85
Active EPFO establishments
1
Employee growth
63.5%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-2785
FY 2025-26
FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21
FY 2019-20
FY 2018-19
FY 2017-18
FY 2016-17

To see the full employee and EPFO history of Charles River Laboratories India Private Limited, buy the company report.

GST

Charles River Laboratories India has 5 GST registrations: 4 active and 1 cancelled or inactive.

Total GSTINs
5
Active
4
Cancelled / inactive
1
GSTINStateStatusRegistered on
29AADCC4876C1ZLKarnatakaActive01 Jul 2017
24AADCC4876C1ZVGujaratActive01 Jul 2017
27AADCC4876C1ZPMaharashtraActive01 Jul 2017
36AADCC4876C1ZQTelanganaActive01 Jul 2017

To see the full GST registrations and return filing status of Charles River Laboratories India Private Limited, buy the company report.

Recent activity

Charles River Laboratories India Private Limited has 19 board changes on record since 2008: 6 appointments and 13 cessations. The latest: Rajesh Puthiya Sudhakaran was appointed as Managing Director on 12 Jan 2026.

Appointed
Rajesh Puthiya Sudhakaran was appointed as Managing Director.
AGM
Charles River Laboratories India Private Limited last Annual general meeting of members was held on 23 Sep 2025 as per latest MCA records.
Appointed
Amro Elabbas was appointed as Additional Director.
Filing
Charles River Laboratories India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore.
Ceased
Jon Galli ceased to be Additional Director.
Appointed
Jon Galli was appointed as Director.
Ceased
Kevin John Finn ceased to be Additional Director.
Ceased
Parampal Deol ceased to be Additional Director.
Appointed
Kevin John Finn was appointed as Director.
Appointed
Parampal Deol was appointed as Director.
Ceased
David Ross Smith ceased to be Director.
Ceased
Foster Timmons Jordan ceased to be Director.

10 earlier events are in the company report.

Frequently asked questions

Charles River Laboratories India is an active private limited company based in Bangalore, Karnataka, India. The company works in medical equipment retail and distribution, within the healthcare industry. It was incorporated on 08 October 2008 (18+ years old) and is registered under CIN U24119KA2008PTC047975.

Charles River Laboratories India has 5 current directors:

The latest financial statements of Charles River Laboratories India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 23 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Charles River Laboratories India is 29AADCC4876C1ZL, registered in Karnataka. The company has 5 GST registrations in all, of which 4 are active and 1 is cancelled or inactive. Other active GSTINs include 24AADCC4876C1ZV (Gujarat), 27AADCC4876C1ZP (Maharashtra), 36AADCC4876C1ZQ (Telangana).

The CIN (Corporate Identification Number) of Charles River Laboratories India is U24119KA2008PTC047975. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Charles River Laboratories India has 1 court case on record: 1 filed by the company.

Charles River Laboratories India was incorporated on 08 October 2008, making it 18+ years old. It is registered with the Registrar of Companies, Bangalore.

Charles River Laboratories India has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹28.78 Cr; the latest was in December 2008.

The peers of Charles River Laboratories India by revenue are G.S.Pharmaceutical Distributors Private Limited, Esaote Asia Pacific Diagnostic Private Limited, Vishal Surgical Equipment Company Private Limited, Decent Medical Equipment Systems Private Limited, Jignesh Agency Private Limited, all in the Healthcare industry (Healthcare Equipment Retail and Distribution), with the same principal business activity (wholesale trading).

Rajesh Puthiya Sudhakaran was appointed as Managing Director on 12 Jan 2026. Amro Elabbas was appointed as Additional Director on 11 Jun 2025. Jon Galli ceased to be Additional Director on 28 Sep 2023. Charles River Laboratories India has 19 board changes on record in total.

Charles River Laboratories India can be reached through the website criver.com. Its registered office is in Bangalore, Karnataka, India.